XCL2 and neoplasm: In line with increased infiltration of CD56bright cells in the TME, the typical CD56bright cellular state was also enriched in five of seven tumor types compared with healthy tissue, with both CD56bright groups exhibiting higher expression of immunomodulatory molecules, including XCL1, XCL2 and IFNG (Fig. 5n–o).